Jasper Therapeutics (JSPRW) Stock Price, News & Analysis

Company Overview

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on the development of targeted protein conjugates for the treatment of cancer and other serious diseases. The company’s research and development efforts center on its proprietary Modular Targeting Conjugate (MTC) platform, which enables the fusion of targeting ligands—such as antibody fragments and affibodies—with diverse therapeutic payloads.

The MTC platform supports the rapid generation and optimization of novel therapeutics by combining binding domains with cytotoxic agents, radionuclides and immunomodulators. Jasper’s lead preclinical candidate, a carcinoembryonic antigen (CEA)-targeted conjugate, has demonstrated promising tumor specificity in preclinical oncology models. Beyond oncology, the company is exploring applications in immuno-oncology and other high-unmet-need areas.

Jasper conducts its research and development activities primarily in North America, with initiatives to extend its clinical programs to Europe and other regions. The company collaborates with academic research institutions and biopharmaceutical partners to advance its pipeline and manufacturing capabilities. Led by a management team of experienced life sciences professionals, Jasper Therapeutics aims to translate its modular platform technology into differentiated therapies for patients worldwide.

Key Stats

• Today's Range: $0.08 to $0.09
• 50-Day Range: $0.08 to $0.30
• 52-Week Range: $0.06 to $0.25
• Volume: 5,700 shs
• Average Volume: 7,778 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

JSPRW Stock Analysis - Frequently Asked Questions

How have JSPRW shares performed this year?

Jasper Therapeutics' stock was trading at $0.2096 at the beginning of 2025. Since then, JSPRW shares have decreased by 52.3% and is now trading at $0.10.

How do I buy shares of Jasper Therapeutics?

Shares of JSPRW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:JSPRW
• CIK: 1788028
• Web: N/A
• Phone: 650-549-1400
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A